Latest Breaking News On - Observational arm - Page 1 : comparemela.com

/PRNewswire/ DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on developing epigenetic modulator programs for the treatment of acute.

United statesUniversity of california san diegoJamese brownCraig mcclainTarek hassaneinUniversity scholar at of louisvilleDrug administrationInnocoll pharmaceuticalsSouthern california research centerSteatohepatitis consortiumInnocoll pharmaceuticals ltdExchange commissionCorporation nasdaqAmerican journalDefeat alcoholic steatohepatitisObservational arm